It was reported that it could raise intracellular GSH by increasing SLC7A11 expression, efficiently leading to GPX4 enhancement and ferroptosis suppression in the ISO-induced injury model of H9C2 cells and rat myocardium [49]
The 50mg starting dose provides effective NNMT inhibition for most individuals while maintaining an excellent safety margin
Sheffield-Moore M, Wiktorowicz JE, Soman KV, Danesi CP, Kinsky MP, Dillon EL, Randolph KM, Casperson SL, Gore DC, Horstman AM, Lynch JP, Doucet BM, Mettler JA, Ryder JW, Ploutz-Snyder LL, Hsu JW, Jahoor F, Jennings K, White GR, McCammon SD, Durham WJ
Who 5-Amino-1MQ Is For and Who Should Avoid It 5-Amino-1MQ has no FDA-approved use, so there is no formal eligibility list
Its been reported that as many as 40% of patients in the US may have suboptimal energy levels